← All Sponsors
SPONSOR

InSilico Medicine Hong Kong Limited

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Idiopathic Pulmonary Fibrosis (IPF)
NCT05975983 Phase 2
Recruiting

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF)
United States View Trial →